Dementia in elderly patients as a consequence of arterial hypertension: a literature review
- Authors: Mikhailov S.S.1, Kozlov K.L.1,2, Shishkevich A.N.1, Bessonov E.Y.1, Lukjanov N.G.1, Pukhalskaya A.E.2
-
Affiliations:
- S.M. Kirov Military Medical Academy
- Saint Petersburg Institute of Bioregulation and Gerontology
- Issue: Vol 3, No 1 (2021)
- Pages: 76-83
- Section: Biomedical Sciences
- URL: https://journals.rcsi.science/PharmForm/article/view/49978
- DOI: https://doi.org/10.17816/phf49978
- ID: 49978
Cite item
Full Text
Abstract
Alzheimer’s disease and vascular dementia are important causes of cognitive decline in the elderly and senile. This problem is becoming increasingly important in connection with the general aging of the world population and an increase in the number of patients with concomitant pathology, among which arterial hypertension plays an important role. There are a number of studies proving the link between arterial hypertension in middle age and dementia in the elderly. It is hoped that the normalization of blood pressure among middle-aged people will reduce the incidence of cognitive dysfunction. It is also known that maintaining blood pressure at acceptable levels in elderly and old people can improve brain function and reduce the prevalence of dementia, but it is not entirely clear which blood pressure numbers are optimal.
Full Text
##article.viewOnOriginalSite##About the authors
Sergey S. Mikhailov
S.M. Kirov Military Medical Academy
Author for correspondence.
Email: mikhailov.vma@gmail.com
SPIN-code: 6284-4693
Ph.D. in Medicine, Senior Resident of the X-ray Surgery Department of the Department of Surgery (Advanced Medical Training) No. 1, S.M. Kirov Military Medical Academy
Russian Federation, St. PetersburgKirill L. Kozlov
S.M. Kirov Military Medical Academy; Saint Petersburg Institute of Bioregulation and Gerontology
Email: kozlov_kl@mail.ru
Doctor of Medicine (MD), Professor, Deputy Director for Educational and Methodological Work, Saint Petersburg Institute of Bioregulation and Gerontology Research Center; Professor of the 1st Department (Surgery for Advanced Medical Doctors) named after P.A. Kupriyanov, S.M. Kirov Military Medical Academy
Russian Federation, St. Petersburg; St. PetersburgAndrey N. Shishkevich
S.M. Kirov Military Medical Academy
Email: vmeda-nio@mil.ru
Doctor of Medicine (MD), Head of the X-ray Surgery Department of the Department of Surgery (Advanced Medical Training) No. 1, S.M. Kirov Military Medical Academy
Russian Federation, St. PetersburgEvgeniy Yu. Bessonov
S.M. Kirov Military Medical Academy
Email: ewgenijbessonov@yandex.ru
resident of the Department of Surgery (Advanced Medical Training) №. 1, S.M. Kirov Military Medical Academy
Russian Federation, St. PetersburgNikolai G. Lukjanov
S.M. Kirov Military Medical Academy
Email: loncori001@rambler.ru
Ph.D. in Medicine, Lecturer of the 1st Department (Surgery for Advanced Medical Doctors) named after P.A. Kupriyanov, S.M. Kirov Military Medical Academy
Russian Federation, St. PetersburgAnastasia E. Pukhalskaya
Saint Petersburg Institute of Bioregulation and Gerontology
Email: nastyapuh96@mail.ru
Researcher of the Laboratory of Age-Related Pathology of the Cardiovascular System, Saint Petersburg Institute of Bioregulation and Gerontology Research Center
Russian Federation, St. PetersburgReferences
- Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005; 366: 2112–17. doi: 10.1016/S0140-6736(05)67889-0.
- Langa MK, Larson EB, Crimmins EM, et al. A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012. JAMA Internal Medicine journal. 2017; 177 (1): 51. doi: 10.1001/jamainternmed.2016.6807.
- Tzourio C. Hypertension, cognitive decline, and dementia: an epidemiological perspective. Dialogues Clin. Neurosci. 2007; 9 (1): 61–70. doi: 10.31887/DCNS.2007.9.1/ctzourio.
- Ritchie K, Kildea D. Is senile dementia “age-related” or “ageing-related”? ence from meta-analysis of dementia prevalence in the oldest old. Lancet. 1995; 346: 931–4. doi: 10.1016/s0140-6736(95)91556-7.
- Rouch L, Cestac P, Hanon O, et al. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms. CNS Drugs. 2015; 29: 113–30. doi: 10.1007/s40263-015-0230-6.
- Qiu C, Winblad B, Fratiglioni L. The age dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005; 4: 487–99. doi: 10.1016/S1474-4422(05)70141-1.
- Joas E, Bäckman K, Gustafson D, et al. Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension. 2012; 59: 796–801. doi: 10.1161/HYPERTENSIONAHA.111.182204.
- Norton S, Matthews FE, Barnes DE, et al. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014; 13: 788–94. doi: 10.1016/S1474-4422(14)70136-X.
- Cerhan JR, Folsom AR, Mortimer JA, et al. Correlates of cognitive function in middle-aged adults. Atherosclerosis risk in communities (ARIC) study investigators. Gerontology. 1998; 44: 95–105. doi: 10.1159/000021991.
- Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30–59 years of age (NHANES III). Neuroepidemiology. 2005; 24: 42–50. doi: 10.1159/000081049.
- Sierra C, de la Sierra A, Salamero M. Silent cerebral white matter lesions and cognitive function in middle-aged essential hypertensive patients. Am. J. Hypertens. 2004; 17: 529–34. doi: 10.1016/j.amjhyper.2004.02.014.
- Shang S, Li P, Deng M. The age-dependent relationship between blood pressure and cognitive impairment: a cross-sectional study in a rural area of Xi’an, China. PLoS ONE. 2016; 11 (7): e0159485. doi: 10.1371/journal.pone.0159485.
- Cacciatore F, Abete P, Ferrara N, et al. The role of blood pressure in cognitive impairment in an elderly population. J. Hypertens. 1997; 15: 135–42. doi: 10.1097/00004872-199715020-00003.
- Tsivgoulis G, Alexandrov AV, Wadley VG, et al. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology. 2009; 73: 589–95. doi: 10.1212/WNL.0b013e3181b38969.
- Vinyoles E, De la Figuera M, Gonzalez-Segura D. Cognitive function and blood pressure control in hypertensive patients over 60 years of age: COGNIPRES study. Curr. Med. Res. Opin. 2008; 24: 3331–9. doi: 10.1185/03007990802538724.
- Scherr PA, Hebert LE, Smith LA, et al. Relation of blood pressure to cognitive function in the elderly. Am J Epidemiol. 1991; 134: 1303–15. doi: 10.1093/oxfordjournals.aje.a116033.
- Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu–Asia aging study. Neurobiol Aging. 2000; 21: 49–55. doi: 10.1016/S0197-4580(00)00096-8.
- Whitmer RA, Sidney S, Selby J, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005; 64: 277–81. doi: 10.1212/01.WNL.0000149519.47454.F2.
- Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle-age in the Whitehall II study. J. Clin. Epidemiol. 2005; 58: 1308–15. doi: 10.1016/j.jclinepi.2005.03.016.
- Abell JG, Kivimäki M, Dugravot A. Association between systolic blood pressure and dementia in the Whitehall II cohort study: role of age, duration, and threshold used to define hypertension. Eur. Heart J. 2018; 39: 3119–25. doi: 10.1093/eurheartj/ehy288.
- Kilander L, Nyman H, Boberg M, et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998; 31: 780–6. doi: 10.1161/01.HYP.31.3.780.
- Farmer ME, Kittner SJ, Abbott RD, et al. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. J. Clin. Epidemiol. 1990; 43: 475–80. doi: 10.1016/0895-4356(90)90136-D.
- McGrath ER, Beiser AS, DeCarli C. Blood pressure from mid to late life and risk of incident dementia. Neurology. 2017; 89: 2447–54. doi: 10.1212/WNL.0000000000004741.
- Lane CA, Barnes J, Nicholas JM. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. Lancet Neurol. 2019; 18: 942–52. doi: 10.1016/S1474-4422(19)30228-5.
- Walker KA, Sharrett AR, Wu A. Association of midlife to late-life blood pressure patterns with incident dementia. JAMA. 2019; 322: 535–45. doi: 10.1001/jama.2019.10575.
- Qiu C, von Strauss E, Fastbom J, et al. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol. 2003; 60: 223–8. doi: 10.1001/archneur.60.2.223.
- Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996; 347: 1141–5. doi: 10.1016/S0140-6736(96)90608-X.
- Glynn RJ, Beckett LA, Hebert LE, et al. Current and remote blood pressure and cognitive decline. JAMA. 1999; 281: 438–45. doi: 10.1001/jama.281.5.438.
- Hebert LE, Scherr PA, Bennett DA, et al. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004; 62: 2021–4. doi: 10.1212/01.WNL.0000129258.93137.4B.
- Pase MP, Beiser A, Enserro D. Association of ideal cardiovascular health with vascular brain injury and incident dementia. Stroke. 2016; 47: 1201–6. doi: 10.1161/STROKEAHA.115.012608.
- Williamson JD, Supiano MA, Applegate WB. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016; 315: 2673–82. doi: 10.1001/jama.2016.7050.
- Williamson JD, Pajewski NM, Auchus AP. Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial. JAMA. 2019; 321: 553–61. doi: 10.1001/jama.2018.21442.
- Yaffe K. Prevention of cognitive impairment with intensive systolic blood pressure control. JAMA. 2019; 321: 548–9. doi: 10.1001/jama.2019.0008.
- Tully PJ, Hanon O, Cosh S, et al. Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies. J Hypertens. 2016; 34 (6): 1027–35. doi: 10.1097/HJH.0000000000000868.
- Ding J, Davis-Plourde KL, Sedaghat S, et al. Antihypertensive medications and risk for incident dementia and Alzheimer’s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol. 2020; 19 (1): 61–70. doi: 10.1016/S1474-4422(19)30393-X.
- Hussain S, Singh A, Rahman SO, et al. Calcium channel blocker use reduces incident dementia risk in elderly hypertensive patients: A meta-analysis of prospective studies. Neurosci Lett. 2018; 671: 120–7. doi: 10.1016/j.neulet.2018.02.027.
- Peters R, Yasar S, Anderson CS, et al. Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis. Neurology. 2020; 94 (3): 267–81. doi: 10.1212/WNL.0000000000008732.
- Хубулава, Г.Г. Особенности артериальной гипертензии у пациентов пожилого и старческого возраста / Г.Г. Хубулава, К.Л. Козлов, С.С. Михайлов. – doi: 10.26347/1607-2499201807-08040-044 // Клиническая геронтология. – 2018. – Т. 24. – № 7-8. – С. 40–44.
- Kjeldsen SE, Narkiewicz K, Burnier M, et al. Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study. Blood Press. 2018; 27: 247–8. doi: 10.1080/08037051.2018.1507621.
Supplementary files
